Owner Xenon Pharmaceuticals Inc. Novartis AG

Inventors Pokrovskaia, Natalia; Zhang, Zaihui; Fu, Jianmin; Dales, Natalie; Sun, Shaoyi; Hou, Duanjie; Kodumuru, Vishnumurthy

Agent Davies Collison Cave

Pub. Number AU-A-2009264242

PCT Pub. Number WO2009/156484

Priority 61/076,443 27.06.08 US

Filing date 25 June 2009

Wipo publication date 30 December 2009

C07D 213/81 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/4439 (2006.01)

A61K 31/444 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group